Alzamend Neuro
ALZN
22 hedge funds and large institutions have $1.49M invested in Alzamend Neuro in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
10% more funds holding
Funds holding: 20 → 22 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
52% less capital invested
Capital invested by funds: $3.13M → $1.49M (-$1.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$25.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11K |
| 3 |
Millennium Management
New York
|
+$9.56K |
| 4 |
Renaissance Technologies
New York
|
+$7.65K |
| 5 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$7.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$11K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.36K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$1.91K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$478 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $12 | – | – | – |
|
|
VF
27
Virtu Financial
New York
| – | -$11K | -16 | Closed |
|
|
CSS
28
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$5.36K | -8 | Closed |
|
|
29
Group One Trading
Chicago,
Illinois
| – | -$1.91K | -4 | Closed |
|
ALZN Hedge Fund Activity: Q3 2023 in Review
22 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q3 2023, worth a combined $1.49M — down 52% from $3.13M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ALZN positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $25.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $11K sold.
- 22 institutional investors held Alzamend Neuro (ALZN) as of Q3 2023, up from 20 in Q2 2023.
- Funds reported $1.49M of Alzamend Neuro stock for Q3 2023, down 52% quarter-over-quarter.
- 5 funds opened new Alzamend Neuro positions in Q3 2023 and 3 closed out, a net change of +2 holders.
- The largest Alzamend Neuro buyer in Q3 2023 was Geode Capital Management, an estimated $25.3K added.
- The largest Alzamend Neuro seller in Q3 2023 was Virtu Financial, an estimated $11K sold.
Based on aggregated 13F filings for Q3 2023.